AZN Astrazeneca PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AZN
- PE Ratio
The current PE ratio for Astrazeneca stock as of Aug 1, 2025 is 27.59. This is calculated based on the TTM EPS of $2.68 and the stock price of $73.95 per share. The PE ratio marks a decrease of 9% from its last 4 quarters average of 30.3.
AZN PE ratio history
The average historical PE ratio of Astrazeneca for the last ten years is 80.25. The current P/E ratio of 27.59 is 66% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $58.25 and the EPS was $0.04. The lowest point was in the Dec 2016 quarter, when it reached 19.65 with a price of $27.32 and an EPS of $1.39.
Astrazeneca PE ratio by year
Maximum annual increase: 3,453.56% in 2021
Maximum annual decrease: -95.61% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 28.86 | -17.73% | $65.52 | $2.27 |
| 2023 | 35.08 | -45.15% | $67.35 | $1.92 |
| 2022 | 63.96 | -95.61% | $67.8 | $1.06 |
| 2021 | 1,456.25 | 3,453.56% | $58.25 | $0.04 |
| 2020 | 40.98 | -57.26% | $49.99 | $1.22 |
| 2019 | 95.88 | 114.59% | $49.86 | $0.52 |
| 2018 | 44.68 | 53.22% | $37.98 | $0.85 |
| 2017 | 29.16 | 48.4% | $34.7 | $1.19 |
| 2016 | 19.65 | -35.17% | $27.32 | $1.39 |
| 2015 | 30.31 | -57.8% | $33.95 | $1.12 |
| 2014 | 71.82 | 146.8% | $35.19 | $0.49 |
| 2013 | 29.1 | 205.35% | $29.69 | $1.02 |
| 2012 | 9.53 | 50.32% | $23.64 | $2.48 |
| 2011 | 6.34 | -23.15% | $23.15 | $3.65 |
| 2010 | 8.25 | -8.64% | $23.1 | $2.8 |
Astrazeneca PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 26.07 | -10.96% | $69.88 | $2.68 |
| Mar 2025 | 29.28 | 1.46% | $73.5 | $2.51 |
| Dec 2024 | 28.86 | -22.21% | $65.52 | $2.27 |
| Sep 2024 | 37.1 | -1.07% | $77.91 | $2.1 |
| Jun 2024 | 37.5 | 13.46% | $77.99 | $2.08 |
| Mar 2024 | 33.05 | -5.79% | $67.75 | $2.05 |
| Dec 2023 | 35.08 | -1.57% | $67.35 | $1.92 |
| Sep 2023 | 35.64 | -0.89% | $67.72 | $1.9 |
| Jun 2023 | 35.96 | -21.24% | $71.57 | $1.99 |
| Mar 2023 | 45.66 | -28.61% | $69.41 | $1.52 |
| Dec 2022 | 63.96 | -34.69% | $67.8 | $1.06 |
| Sep 2022 | 97.93 | N/A | $54.84 | $0.56 |
| Jun 2022 | N/A | N/A | $66.07 | -$0.53 |
| Mar 2022 | N/A | N/A | $66.34 | -$0.43 |
| Dec 2021 | 1,456.25 | 1,476.03% | $58.25 | $0.04 |
AZN Price vs fair value
AZN average PE ratio chart
Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.
AZN PE vs peers
In comparison to its peer LLY, AZN's PE ratio is lower, but it is higher than JNJ's and NVS's. Astrazeneca's PE ratio is trading above the peer average of 21.37.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.51 | $199.1B |
| BIIB Biogen Inc | 12.59 | $19.35B |
| ABT Abbott Laboratories | 15.91 | $221.54B |
| NVS Novartis AG | 16.69 | $223.21B |
| PFE Pfizer Inc | 16.9 | $133.55B |
| BMY Bristol Myers Squibb Co | 17.76 | $90.03B |
| JNJ Johnson & Johnson | 17.78 | $402.99B |
| AZN Astrazeneca plc | 27.59 | $229.25B |
| LLY ELI LILLY & Co | 61.78 | $722.49B |
Frequently asked questions
What is Astrazeneca's PE ratio?
AZN stock has a price to earnings ratio of 27.59 as of Aug 1, 2025.
What is the 3-year average PE ratio for Astrazeneca (AZN)?
The 3-year average price to earnings ratio for AZN stock is 42.17.
What is the 5-year average PE ratio for Astrazeneca (AZN)?
The 5-year average price to earnings ratio for AZN stock is 123.76.
What is the highest PE ratio for AZN?
Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.
How does the current PE ratio for AZN compare to its historical average?
The current PE ratio of AZN is 66% lower than the 10-year historical average.
How is AZN's PE ratio calculated (Astrazeneca PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Aug 1, 2025), Astrazeneca's share price is $73.95. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $2.68. Therefore, Astrazeneca's PE ratio for today is 27.59. PE RATIO(27.59) = STOCK PRICE($73.95) / TTM EPS($2.68)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.